๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Educational material about genetic tests: Does it provide key information for patients and practitioners?

โœ Scribed by Cho, M. K.; Arruda, M.; Holtzman, N. A.


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
36 KB
Volume
73
Category
Article
ISSN
0148-7299
DOI
10.1002/(sici)1096-8628(19971219)73:3<314::aid-ajmg16>3.0.co;2-m

No coin nor oath required. For personal study only.

โœฆ Synopsis


Genetic testing for common conditions will be used increasingly in primary care, but resources for patient counseling are decreasing. It is also necessary that primary care practitioners be better equipped to do basic genetic counseling. Therefore, the quality of informational materials for practitioners and patients is important. It was unknown how often key elements recommended by policy groups were actually included in such material. It was our aim to determine the content of printed informational material for practitioners and patients on genetic testing. We performed (1) a telephone survey of organizations in the United States that developed genetic tests or services and (2) a content analysis of pamphlets obtained from these organizations to determine the presence of 10 critical elements necessary to evaluate the appropriateness and performance of the tests. Almost 95% (169/178) of organizations responded to our survey; 131/ 169 (78%) reported using informational materials. We analyzed 115 pamphlets collected from 125/131 (95%) organizations. Elements least frequently included in the pamphlets were risks and benefits, patient rights, and intended use or purpose of the test. Most frequently included were descriptions of the conditions detected by the test, and the appropriate patients for testing. Nearly one half of the pamphlets included some statement about the accuracy of the test, but most of these did not specify whether their statements referred to sensitivity, specificity, or predictive value. Overall, pamphlets tended to contain information that would aid in determining a patient's eligibility for a genetic test, but did not con-tain sufficient information about the tests themselves. Our results suggest that several critical elements need to be added to enhance informed choices by patients and physicians. Am. J. Med. Genet. 73:314-320, 1997.


๐Ÿ“œ SIMILAR VOLUMES


Patients' attitudes about autonomy and c
โœ Benkendorf, Judith L.; Reutenauer, Jeri E.; Hughes, Chanita A.; Eads, Nadine; Wi ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 40 KB ๐Ÿ‘ 2 views

The identification of BRCA1 and BRCA2, two breast-ovarian cancer susceptibility genes, has brought many ethical and social issues to the forefront. This paper presents the results of a survey assessing the attitudes of 238 unaffected first-degree relatives of women with breast or ovarian cancer rega

Commercialization ofBRCA1/2 testing: Pra
โœ Cho, M.K.; Sankar, P.; Wolpe, P.R.; Godmilow, L. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 26 KB ๐Ÿ‘ 1 views

## It was our purpose to determine the characteristics of practitioners in the United States who were among the first to inquire about and use the BRCA1 and BRCA2 (BRCA1/2) genetic tests outside of a research protocol. Questionnaires were mailed to all practitioners who requested information on or

Testing for inherited susceptibility to
โœ Durfy, Sharon J.; Buchanan, Trisha E.; Burke, Wylie ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 31 KB ๐Ÿ‘ 1 views

The identification of genetic mutations linked to breast cancer has made it possible to test for the genetic predisposition to this disease. However, though this test may provide certain benefits, there are also potential risks involved with the testing process, including social and economic conside

Genetic epidemiological study of materna
โœ Ehrenkrantz, David; Silverman, Jeremy M.; Smith, Christopher J.; Birstein, Sandr ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 30 KB ๐Ÿ‘ 1 views

Recent evidence for mitochondrial mutations associated with Alzheimers disease (AD) suggests the possibility of maternal transmission of this illness. We investigated this hypothesis by examining, in a variety of ways, the risk of a primary progressive dementia (PPD) in the parents (n = 650) and sib